Protara Therapeutics

Developer of cell therapies to treat lymphatic malfunctions

placeNew York City, New York, United States calendar_todayFounded 2017 groups25 employees language protaratx.com

Registered entities

Investor mix

10 investors on record.

Investor typeCountShare
Venture capital440%
Private equity110%
Other / undisclosed550%
Coming soon